Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
56 participants
INTERVENTIONAL
2022-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Security Testing of a Mobile App for Self-Managing Emotion Dysregulation
NCT04210648
A Pilot Study of a Blended Intervention Targeting Emotion Dysregulation in Adults with ADHD
NCT05644028
Loves Company: Combatting Emotional Disturbance in the Digital Age
NCT03443206
The Therapeutic Mechanism of Compassion-Based Family Intervention
NCT07138417
Optimization of a Mobile Transdiagnostic Emotion Regulation Intervention for University Students
NCT05576883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
psychotherapeutic intervention with class risk A (low risk, no invasive procedure)
an eight-week emotion regulation group intervention
Emotion regulation group
90 minute sessions once a week for 8 weeks, in groups of eight participants. DBT, MBT and MBI inspired, psychoeducative intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emotion regulation group
90 minute sessions once a week for 8 weeks, in groups of eight participants. DBT, MBT and MBI inspired, psychoeducative intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 4 criteria of borderline symptoms (out of the 9 listed in the DSM-5) including emotional liability
* French speaking
* Availability during the whole study
* Willingness in participating to the intervention and the research
* Informed consent read and signed
Exclusion Criteria
* Psychotic disorder
* Severe and persistent substance addiction
* Antisocial personality disorder
* Inability to participate in group sessions
* Current pregnancy
* Non-French speaking
* Previous enrolment into the current study
16 Years
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Privée des HUG
UNKNOWN
Camille Nemitz Piguet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Camille Nemitz Piguet
MD, PhD, PD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpitaux Universitaires de Genève (HUG)
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-01883
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.